China SXT Pharmaceuticals, Inc. Class A Ordinary Shares
SXTC
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly TCMP (Directed-oral TCMP and After-soaking TCMP), which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
Last trade$0.00
Day change$0.00 (0.00%)
Day range$2.82 – $3.03
Volume32,030
Market cap$0M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for SXTC.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for SXTC.
Recent news
Company coverage with links to the original publishers.
Univest Securities completed a $10 million registered direct offering for China SXT Pharmaceuticals (NASDAQ: SXTC), a specialty pharmaceutical company focused on Traditional Chinese Medicine products. The company sold approximately 66.67 million Class A ordinary shares at $0.15 per share to a single investor.
China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) announced a registered direct offering of 66.67 million Class A ordinary shares at $0.15 per share, expected to raise approximately $10 million. The transaction is expected to close on January 12, 2026. The company is a specialty pharmaceutical firm focused on traditional Chinese medicine products.
China SXT Pharmaceuticals, Inc. (SXTC) announced a 1-for-8 share consolidation to regain compliance with the Nasdaq's minimum bid price requirement of $1.00 per share. The company's shares will begin trading on a post-consolidation basis on February 25, 2025.
Ericsson reported better-than-expected Q2 sales and issued guidance, causing its shares to rise in pre-market trading. Several other stocks also saw significant pre-market movement, both positive and negative.
Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.
Travelers reported a mixed first quarter, with earnings lagging analyst' expectations. Core income per share reached $4.69 from $4.11 a year ago, missing the $4.90 consensus forecast. Net income per share rose to $4.80 from $4.13 a year earlier.
Travelers shares dipped 8.1% to $205.03 on Wednesday.
Here are some other stocks moving in today's mid-day session.
Gainers
INVO Bioscience, Inc. (NASDAQ: INVO) shares shot up 256% to $2.78 after the company reported a year-over-year increase in fourth-quarter revenue results and said it remains on track to reach its goal of reaching break-even or profitability within its current operations in 2024.
Edible Garden AG Incorporated (NASDAQ: EDBL) gained 112% to $9.73 after the company reported preliminary first quarter FY24 results.
Sintx Technologies, Inc. (NASDAQ: SINT) jumped 53% to $0.0350.
VIA optronics AG (NYSE: VIAO) shares gained 50.4% to $0.3924 after dipping over 15% on Tuesday.
AERWINS Technologies Inc. (NASDAQ: AWIN) jumped 42.2% to $4.70.
The Children's Place, Inc. (NASDAQ: PLCE) climbed 35.5% to $9.64 after the company announced it entered into a new financing agreement with Mithaq Capital.
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) gained 32% to $5.38 after the company announced that it submitted three proposals since February to acquire all of the outstanding shares of common stock of Vanda Pharmaceuticals and confirmed that its most recent proposal to acquire Vanda remains open for Vanda and its Board of Directors to consider.
EZGO Technologies Ltd. (NASDAQ: EZGO) gained 28% to $2.20. EZGO entered into a strategic cooperation framework agreement with Woteam to jointly explore the Southeast Asian Market.
CXApp Inc. (NASDAQ: CXAI) shares rose 25% to $4.89 after the company announced 24% ARR growth in 2023.
TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) rose 19.6% to $2.0461.
WiSA Technologies, Inc. (NASDAQ:
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.